International Journal of Case Reports and Images (IJCRI) is an international, peer reviewed, monthly, open access, online journal, publishing high-quality, articles in all areas of basic medical sciences and clinical specialties.Aim of IJCRI is to encourage the publication of new information by providing a platform for reporting of unique, unusual and rare cases which enhance understanding of disease process, its diagnosis, management and clinico-pathologic correlations. Case Report: We report a case of palytoxin inhalational toxicity in pediatric siblings following secondary exposure to vapors from cleaning of an aquarium containing Zoanthids. Symptoms included fever, tachycardia, leukocytosis and elevated lactic dehydrogenase. Both patients received supportive treatment in the pediatric intensive care unit and were discharged after 48 hours. Symptoms also occurred in children's parents including cleaning attendant. Conclusion: Herein, we present a rare case of inhalational toxicity from palytoxin.

No abstract

The following articles from The Medical Letter have been selected on the basis of their importance to obstetrician-gynecologists. For information on how to subscribe to The Medical Letter, go to http://medicalletter.org/tml/obgyn.

The following articles from The Medical Letter have been selected on the basis of their importance to obstetrician-gynecologists. For information on how to subscribe to The Medical Letter, go to http://medicalletter.org/tml/obgyn.

once daily to dry, intact skin on the abdomen, upper arms/shoulders or thighs. The gel should be gently rubbed into the skin until it dries; patients should not shower for 1 hour after application. The same application site should not be used on consecutive days. CONCLUSIONOxybutynin topical gel (Gelnique) offers a modestly effective alternative to oral medications for treatment of overactive bladder. How it compares in efficacy to other formulations of oxybutynin or to any other antimuscarinic drug approved to treat overactive bladder remains to be determined. The gel may cause a lower incidence of local skin reactions than the transdermal patch formulation of oxybutynin and might, like the patch, cause less dry mouth and constipation than oral formulations.